Criminals.
"Government clinical trial investigators changed the primary metric for measuring the success of Gilead’s experimental drug remdesivir as a coronavirus treatment two weeks before Anthony S. Fauci’s announcement that the drug would be the new “standard of care.”Instead of counting how many people taking the drug were kept alive on ventilators or died, among other measures, the National Institute of Allergy and Infectious Diseases said it would judge the drug primarily on a different outcome: how long it took surviving patients to recover.Death and other negative outcomes were moved to secondary measure status: They would still be tracked, but they would no longer be the key measure of remdesivir’s performance. The switch — which specialists said is unusual in major clinical trials but not unheard of — was publicly disclosed on the government’s clinicaltrials.gov website on April 16 but did not receive much attention at the time."
https://www.msn.com/en-us/news/us/government-researchers-changed-metric-to-measure-coronavirus-drug-remdesivir-during-clinical-trial/ar-BB13ui2k
- Forums
- International Markets
- BBUS
Criminals."Government clinical trial investigators changed the...
-
- There are more pages in this discussion • 11,685 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SP500 (INDEXSP) to my watchlist
|
|||||
Last
2,958.8 |
Change
17.070(0.58%) |
Mkt cap ! n/a |
Open | High | Low |
2,958.8 | 0.00 | 0.00 |
Featured News
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, MD & CEO
Anthony Noble
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online